Why Vertex Ventures HC: Interviews, Careers, & Portfolio

Vertex Ventures HC Overview

Vertex Ventures HC (VVHC) is part of the global venture fund network under Vertex Holdings. 

Founded in 2014 and based in San Francisco, California, VVHC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices, and digital health.

VVHC’s portfolio includes companies at all stages, from early preclinical to commercial-stage businesses looking to grow. They focus on areas with significant unmet needs, aiming to build companies that improve health and quality of life.

The firm takes an active role in helping their portfolio companies, working closely with entrepreneurs, industry partners, and other investors to create value for shareholders and patients.

They offer their expertise to companies worldwide, with investment teams in San Francisco and Boston scouting for promising opportunities in the U.S., Europe, Asia, and beyond.

Vertex Ventures HC AUM

According to the official website of Vertex Ventures HC, the firm has $500 million in assets under management.

Vertex Ventures HC Interview Process & Questions

Firms can vary their interview process for each candidate, but if you’re interviewing at Vertex Ventures HC (or a similar firm), you can typically expect:

• Around 4-6 interview rounds.
• Initial interviews led by junior investment professionals or the HR team, with more senior staff conducting later rounds.
• Interview process that usually spans several weeks, unless it’s part of “on-cycle” or “on-campus” recruiting.

Interviews at Vertex Ventures HC include a mix of fit, behavioral, and technical/investing questions.

If you need help preparing for interviews, consider using my Growth Equity Interview Guide.

Why Vertex Ventures HC

One of the most common and crucial interview questions is, “Why this firm?”

If you’ve networked with people at the firm, mention those you’ve met and the positive impressions they left on you.

It’s also essential to research the firm before the interview. A great way to learn more about the firm is by listening to interviews with its founders or investors.

Here’s an interview with Lori Hu, Managing Director of Vertex Ventures HC, to help you get started:

More Interview

• Interview with Christine Brennan, Managing Partner at VVHC

Vertex Ventures HC Case Study

Interviewees typically encounter a case study during the interview process. Case studies allow firms to evaluate your technical skills and communication abilities.

At firms like Vertex Ventures HC, these case studies generally involve financial modeling and making investment recommendations. For junior roles, you might also be asked to perform a cold calling case study.

Want to prepare for case studies? Consider using my Growth Equity Interview Guide.

Vertex Ventures HC Salary & Compensation

According to Salary.con, Investment Associates at Vertex Ventures HC earns an estimated total pay of $105K per year, while there’s no recent salary data for analyst hires.

Figures will vary depending on several factors that firms typically consider such as experience, education, and skills.

Associate

Vertex Ventures HC Careers, Jobs, & Internships

To see open roles at Vertex Ventures HC, check out our job board which features all open roles for them and other similar firms.

Vertex Ventures HC Portfolio & Investments

According to Crunchbase, Vertex Ventures HC has made 38 investments across four funds. Some of their notable deals include Eyebiotech, Septerna, and Spyglass Pharma.

Notable Transaction: NeuSpera Medical

Neuspera Medical, a company dedicated to developing implantable medical devices to improve the lives of patients with chronic illnesses, has announced the successful closing of its Series D funding round.

This round raised $23 million and was led by Vertex Ventures HC and Treo Ventures, with additional participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures, and another strategic investor.

Neuspera’s innovative platform aims to provide patients and physicians with new, earlier treatment options that are less invasive and more adaptable. The Neuspera Implantable Sacral Neuromodulation (SNM) System exemplifies this mission, offering therapeutic alternatives designed to restore health and enhance the quality of life for patients.

The funding round, announced on July 15, 2024, marks a significant milestone for Neuspera Medical, allowing the company to continue its pioneering work in the field of neuromodulation.

Next Steps

If you’re aiming to join Vertex Ventures HC as a professional investor, my Growth Equity Interview Guide is a valuable resource.

This self-paced online course is ideal for anyone wanting to break into growth equity, providing you with the tools to improve your chances of landing your dream role. It covers all the key areas you’ll encounter in interviews, such as case studies and financial modeling.

Start preparing for your interviews now!